Search - tctmd.com

Displaying 621 - 640 of 681

Sort: Relevancy | Date

News Daily News

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Caitlin E. Cox

January 17, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Daily News

Study Shines Spotlight on US Readmissions After STEMI

Yael L. Maxwell

January 04, 2012

Presentation TCT 2012

The New 320-Row Computed Tomography With Lower Radiation Exposure to Rule-out Coronary Artery Disease in Patients with Atrial Fibrillation

Presenter: Francesco Pelliccia, Antonietta Evangelista, Amedeo Pergolini, Vincenzo Pasceri, Nicola Viceconte, Giuseppe Pannarale, Salvatore Varrica, Susanna Romitelli, Massimo Pellegrini, Carlo Gaudio

January 03, 2012

News Daily News

New-Onset A-fib After Percutaneous Valve Repair More Common Than Thought

December 13, 2011

News Industry News

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

November 15, 2011

News Industry News

Boston Scientific Begins Marketing Remote Catheter System in Europe through Exclusive Agreement with Catheter Robotics

November 14, 2011

News Daily News

Surgical, Transcatheter Valve Therapies Show Similar Long-term Benefits

Jason Kahn

November 06, 2011

News Industry News

Real-World TAVI Results Mirror Clinical Trials

November 06, 2011

News Conference News

New Stem Cell Therapies Promising in Severe Heart Disease

November 06, 2011

News Conference News

Coming to Grips with CLOSURE I: PFO Device Plus Medical Therapy Not Superior to Medical Therapy Alone

November 06, 2011

News Industry News

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

November 04, 2011

News Industry News

FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation

October 27, 2011

News Industry News

Medtronic Announces Results From TTOP-AF Trial Demonstrating Clinical Benefits of Its Phased RF Ablation System in Treating Persistent Atrial Fibrillation

October 10, 2011

News Daily News

Hope Renewed for Novel Anticoagulant Use in ACS

Caitlin E. Cox

October 05, 2011

News Daily News

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Caitlin E. Cox

September 14, 2011

News Daily News

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

L.A. McKeown

September 13, 2011

News Industry News

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

September 08, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

Advertisement

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

Study Shines Spotlight on US Readmissions After STEMI

The New 320-Row Computed Tomography With Lower Radiation Exposure to Rule-out Coronary Artery Disease in Patients with Atrial Fibrillation

New-Onset A-fib After Percutaneous Valve Repair More Common Than Thought

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

Boston Scientific Begins Marketing Remote Catheter System in Europe through Exclusive Agreement with Catheter Robotics

Surgical, Transcatheter Valve Therapies Show Similar Long-term Benefits

Real-World TAVI Results Mirror Clinical Trials

New Stem Cell Therapies Promising in Severe Heart Disease

Coming to Grips with CLOSURE I: PFO Device Plus Medical Therapy Not Superior to Medical Therapy Alone

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation

Medtronic Announces Results From TTOP-AF Trial Demonstrating Clinical Benefits of Its Phased RF Ablation System in Treating Persistent Atrial Fibrillation

Hope Renewed for Novel Anticoagulant Use in ACS

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

ESC Congress 2011: Drugs, Devices Work Together

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content